+987.9%
MRNA vs NTAP
+66.6%
+921.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NTAP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -1.6% | +14.7% | +12.7% |
| 7D | +20.6% | -16.1% | +36.7% | +15.3% |
| 30D | +27.1% | -15.9% | +43.1% | +21.2% |
| 3M | +353.4% | -1.2% | +354.6% | +345.7% |
| 6M | +446.3% | +70.1% | +376.2% | +379.3% |
| YTD | +776.2% | +77.9% | +698.2% | +638.6% |
| 1Y | +987.9% | +68.1% | +919.8% | +853.8% |
| All | +987.9% | +66.6% | +921.3% | +853.8% |
Cumulative growth
Daily Returns
Daily percentage return beside NTAP.
Daily Out/Under-Performance
Portfolio return minus NTAP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling